Hajime Kubo Selected Research

Hajime Kubo Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 06/2002
8	Hypertrophy 01/2023 - 07/2006
8	Fibrosis (Cirrhosis) 01/2023 - 03/2006
8	Myocardial Infarction 10/2021 - 03/2012
5	Heart Failure 12/2021 - 07/2006
4	Infarction (Infarctions) 11/2023 - 10/2012
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 06/2005
3	Hypertension (High Blood Pressure) 11/2007 - 06/2005
2	Body Weight (Weight, Body) 11/2018 - 11/2007
2	Cardiac Arrhythmias (Arrythmia) 09/2017 - 03/2012
2	Cardiotoxicity 10/2014 - 05/2014
2	Necrosis 05/2014 - 08/2010
2	Esophageal Neoplasms (Esophageal Cancer) 12/2011 - 07/2007
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2007 - 12/2006
2	Lung Injury 12/2006 - 03/2006
2	Lung Neoplasms (Lung Cancer) 12/2006 - 03/2006
2	Lymphatic Metastasis 04/2004 - 06/2002
1	Hypothyroidism 10/2023
1	Hematoma 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Ischemia 12/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021
1	Cicatrix (Scar) 10/2021
1	Moyamoya Disease (Moya-Moya Disease) 01/2021
1	Infections 01/2020
1	Skin Diseases (Skin Disease) 01/2020
1	Pruritus (Itching) 01/2020
1	Fever (Fevers) 01/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2020
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2020
1	Ventricular Remodeling 12/2017
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 09/2017
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Dehydration (Water Stress) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 10/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2014
1	Heart Diseases (Heart Disease) 08/2013

Drug/Important Bio-Agent (IBA)

5	Interleukin-6 (Interleukin 6)IBA 11/2008 - 03/2006
4	CytokinesIBA 11/2023 - 03/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 11/2008 - 12/2006
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2008 - 12/2006
3	salicylhydroxamic acid (SHAM)IBA 10/2023 - 08/2013
3	RNA (Ribonucleic Acid)IBA 12/2021 - 12/2006
3	Messenger RNA (mRNA)IBA 11/2008 - 12/2006
3	CollagenIBA 11/2008 - 12/2006
3	Adrenergic Agents (Adrenergic Drugs)IBA 11/2007 - 06/2005
3	beta Adrenergic ReceptorsIBA 11/2007 - 06/2005
3	DNA (Deoxyribonucleic Acid)IBA 07/2007 - 03/2003
3	Vascular Endothelial Growth Factor DIBA 03/2005 - 06/2002
3	Vascular Endothelial Growth Factor CIBA 04/2004 - 06/2002
2	Transient Receptor Potential ChannelsIBA 08/2014 - 11/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 07/2007
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2013 - 06/2002
2	CalcineurinIBA 11/2012 - 11/2007
2	LigandsIBA 09/2009 - 06/2002
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2008 - 07/2007
2	phospholambanIBA 11/2007 - 07/2006
2	Inosine FDA Link 07/2007 - 12/2006
2	Complementary DNA (cDNA)IBA 07/2007 - 12/2006
2	Adenosine (Adenocard)FDA LinkGeneric 07/2007 - 12/2006
2	Proteins (Proteins, Gene)FDA Link 07/2006 - 06/2005
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 04/2004 - 06/2002
1	Oxygen (Dioxygen)IBA 01/2023
1	Atrial Natriuretic Factor (ANF)IBA 01/2023
1	EnbucrilateIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	Vorinostat FDA Link 01/2023
1	Therapeutic UsesIBA 12/2021
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2021
1	Angiotensin IIIBA 01/2021
1	NivolumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Histamine H1 AntagonistsIBA 01/2020
1	Histamine Antagonists (Antihistamines)IBA 01/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	rupatadineIBA 01/2020
1	VaccinesIBA 01/2020
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 11/2018
1	Protein Kinase CIBA 12/2017
1	ruboxistaurinIBA 12/2017
1	myosin-binding protein CIBA 09/2017
1	Stromal Interaction Molecule 1IBA 07/2017
1	CanagliflozinIBA 01/2017
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2017
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 10/2015
1	Imatinib Mesylate (Gleevec)FDA Link 10/2014
1	CalciumIBA 10/2014
1	Tyrosine Kinase InhibitorsIBA 10/2014
1	Sorafenib (BAY 43-9006)FDA Link 05/2014
1	Bromodeoxyuridine (BrdU)IBA 05/2014
1	Caspase 3 (Caspase-3)IBA 10/2012
1	Contractile ProteinsIBA 10/2012
1	Biocompatible Materials (Biomaterials)IBA 10/2012
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2012

Therapy/Procedure

11	Therapeutics 12/2021 - 06/2002
4	Radiotherapy 01/2023 - 03/2006
1	Injections 10/2015